TRILUMINATE's primary endpoint was a hierarchical composite of death from any cause or tricuspid valve surgery, ...
Abbott (NYSE: ABT) today announced data demonstrating substantial, sustained improvements with its TriClip system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback